Case Report: Neoadjuvant chemoimmunotherapy achieving pathological complete response in two cases of stage III EGFR-mutant NSCLC with high PD-L1 expression - Quiz - MDSpire

Case Report: Neoadjuvant chemoimmunotherapy achieving pathological complete response in two cases of stage III EGFR-mutant NSCLC with high PD-L1 expression

  • By

  • Diming Wang

  • Tangbin Liu

  • Jian Zhao

  • Bowen Ding

  • Yongliang Niu

  • June 17, 2026

  • 0 min

Share

Original Source(s)

Case Report: Neoadjuvant chemoimmunotherapy achieving pathological complete response in two cases of stage III EGFR-mutant NSCLC with high PD-L1 expression

  • by Diming Wang, Tangbin Liu, Jian Zhao, Bowen Ding, Yongliang Niu

  • June 17, 2026

Related Content

Editorial: Innovative strategies in overcoming glioblastoma: advancements in treatment and research

Case Report: Tislelizumab combined with bevacizumab in the treatment of primary malignant pericardial mesothelioma

Optical coherence tomography features and visual prognosis in vitreoretinal lymphoma: a structured phenotyping study